Fundz

Fundz Deep Dive

Everything you need to win Pamela Garzone — in one platform.

Who to reach, what to say, and why now on Pamela Garzone — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Pamela Garzone — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Anixa Biosciences Appoints Suyasha Gupta As Senior Director of Clinical Development

PUBLIC · ANIXOct 07, 2024•over 1 year ago

Position

Chief Development Officer

Company

Anixa Biosciences

Pamela Garzone
United StatesBiotechnologyHealth CareTherapeutics

Description

Anixa Biosciences announced the appointment of Suyasha Gupta as Senior Director of Clinical Development, who will work closely with Dr. Pamela Garzone, Chief Development Officer, to oversee the Company's ongoing Phase 1 breast cancer vaccine and Phase 1 ovarian cancer CAR-T therapy clinical trials, as well as the upcoming Phase 2 breast cancer vaccine clinical trial.

Company Information

Company

Anixa Biosciences

Location

United States

About

Anixa Biosciences, Inc. is a biotechnology company focused on developing innovative therapies for various types of cancers and infectious diseases. The company is primarily engaged in the research and development of immunotherapies and vaccines, with key products including a novel cancer vaccine and T-cell therapies. Anixa operates in the global biotechnology market, serving healthcare sectors by addressing significant unmet medical needs. The firm is headquartered in San Jose, California and is publicly traded on the NASDAQ under the symbol 'ANIX'. Recently, Anixa has emphasized on advancing its clinical studies and establishing partnerships to enhance its product pipeline.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Anixa Biosciences's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.